We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+11.01%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$380M
AUM Growth
+$51.2M
Cap. Flow
+$18.7M
Cap. Flow %
4.92%
Top 10 Hldgs %
38.28%
Holding
210
New
18
Increased
73
Reduced
84
Closed
3

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$7.91M
2
ABT icon
Abbott
ABT
+$7.76M
3
BND icon
Vanguard Total Bond Market
BND
+$1.35M
4
OGN icon
Organon & Co
OGN
+$938K
5
V icon
Visa
V
+$610K

Top Sells

Rank Stock Value
1
CERN
Cerner Corp
CERN
+$1.16M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$665K
3
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$620K
4
VPL icon
Vanguard FTSE Pacific ETF
VPL
+$599K
5
BABA icon
Alibaba
BABA
+$439K

Sector Composition

Rank Sector Weight
1 Healthcare 25.08%
2 Technology 16.71%
3 Financials 10.29%
4 Industrials 9.17%
5 Communication Services 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBUX icon
26
Starbucks
SBUX
$120B
$3.68M 0.97%
31,440
-279
-0.9% -$31.5K
BND icon
27
Vanguard Total Bond Market
BND
$157B
$3.65M 0.96%
43,052
+15,899
+59% +$1.35M
VTEB icon
28
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
$3.44M 0.9%
62,649
+2,644
+4% +$145K
ANET icon
29
Arista Networks
ANET
$225B
$3.37M 0.89%
93,800
-2,360
-2% -$70.4K
PG icon
30
Procter & Gamble
PG
$335B
$3.3M 0.87%
20,177
-20
-0.1% -$2.97K
DGX icon
31
Quest Diagnostics
DGX
$25.9B
$3.09M 0.81%
17,863
+134
+0.8% +$20.4K
MGV icon
32
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.2B
$2.82M 0.74%
26,371
-1,827
-6% -$189K
CEF icon
33
Sprott Physical Gold and Silver Trust
CEF
$7.39B
$2.73M 0.72%
153,937
+1,100
+0.7% +$19.5K
WMT icon
34
Walmart Inc
WMT
$887B
$2.68M 0.7%
55,491
-543
-1% -$25.9K
LIN icon
35
Linde
LIN
$222B
$2.63M 0.69%
7,578
-1,215
-14% -$394K
CNC icon
36
Centene
CNC
$30.7B
$2.62M 0.69%
31,754
+1,170
+4% +$85.7K
GILD icon
37
Gilead Sciences
GILD
$161B
$2.62M 0.69%
36,040
-720
-2% -$49.6K
MTB icon
38
M&T Bank
MTB
$35.9B
$2.52M 0.66%
16,430
+35
+0.2% +$5.37K
VIG icon
39
Vanguard Dividend Appreciation ETF
VIG
$111B
$2.5M 0.66%
14,543
-25
-0.2% -$4.12K
RTX icon
40
RTX Corp
RTX
$289B
$2.49M 0.65%
28,920
-115
-0.4% -$10K
UNP icon
41
Union Pacific
UNP
$174B
$2.48M 0.65%
9,838
-35
-0.4% -$8.29K
CVS icon
42
CVS Health
CVS
$134B
$2.47M 0.65%
23,973
+1,030
+4% +$95.2K
DIS icon
43
Walt Disney
DIS
$166B
$2.4M 0.63%
15,523
+110
+0.7% +$17.8K
AMGN icon
44
Amgen
AMGN
$207B
$2.23M 0.59%
9,889
-43
-0.4% -$9.07K
CHRW icon
45
C.H. Robinson
CHRW
$17.8B
$2.2M 0.58%
20,455
-1,210
-6% -$118K
INTU icon
46
Intuit
INTU
$86.2B
$2.18M 0.57%
3,394
-73
-2% -$45.1K
BDX icon
47
Becton Dickinson
BDX
$45.3B
$2.01M 0.53%
8,208
– –
VBR icon
48
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
$2.01M 0.53%
11,219
+1,159
+12% +$206K
XOM icon
49
ExxonMobil
XOM
$635B
$2M 0.53%
32,630
-957
-3% -$59.8K
VWO icon
50
Vanguard FTSE Emerging Markets ETF
VWO
$120B
$1.95M 0.51%
39,349
-194
-0.5% -$9.78K
1
2
3 4 5

Similar funds

VBFP
Valtinson Bruner Financial Planning New Brighton, Minnesota $364M AUM 9.63% 1-Year Est. Return
EW
Evexia Wealth Stevens Point, Wisconsin $364M AUM 29.61% 1-Year Est. Return
RBFC
Roman Butler Fullerton & Co St Louis, Missouri $364M AUM 27.64% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
DCP
Davern Capital Partners Ny, New York $365M AUM
MA
Modus Advisors Excelsior, Minnesota $363M AUM 22.99% 1-Year Est. Return
SWA
Strata Wealth Advisors Dallas, Texas $365M AUM 16.8% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Roberts, Glore & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Roberts, Glore & Co held 210 positions worth $380M, up 16% from $329M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Roberts, Glore & Co deployed $18.7M of net new capital in Q4 2021, opening 18 new positions and adding to 73 existing holdings. Its largest new stake was Organon & Co: 28,791 shares worth $877K.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Cerner Corp, an estimated $1.16M trimmed.

  • Roberts, Glore & Co's largest Q4 2021 buy was Organon & Co: 28,791 shares worth $877K.
  • Roberts, Glore & Co added most to AbbVie in Q4 2021, an estimated $7.91M increase.
  • Roberts, Glore & Co's biggest Q4 2021 reduction was Cerner Corp, cutting an estimated $1.16M.
  • Roberts, Glore & Co fully exited Dell in Q4 2021, selling an estimated $298K.
  • Roberts, Glore & Co's ten largest holdings make up 38% of its $380M portfolio in Q4 2021.
  • Roberts, Glore & Co opened 18 new positions and closed 3 in Q4 2021.
  • Roberts, Glore & Co's portfolio value rose 16% quarter-over-quarter to $380M.

Based on Roberts, Glore & Co's 13F filing for Q4 2021, filed 11 Feb 2022.